Split-Dosing Regimen Granted FDA Approval for Multiple Myeloma Treatment
February 12th 2019Daratumumab was first approved in November 2015 as the first and only CD38-directed antibody for the treatment of patients with multiple myeloma who have received at least 3 prior lines of therapy, including a proteasome inhibitor (PI) and an immunomodulatory agent, or who are double refractory to both.
Read More
Pharmacists Are Happy With Their Salaries, Less So With Their Jobs, Survey Shows (Part 2)
February 12th 2019Although many pharmacists are divided when it comes to their job satisfaction, most of them are currently happy with their compensation, according to a recent Pharmacy Times® Salary and Job Satisfaction Survey.
Read More
FDA Grants Priority Review to Keytruda for First-Line Treatment of Head and Neck Cancer
February 11th 2019The supplemental Biologics License Application was filed based on positive overall survival data from a phase 3 clinical trial for pembrolizumab in the treatment of recurrent or metastatic head and neck squamous cell carcinoma.
Read More